Introduction
Low-renin hypertension is an under-recognised subtype of hypertension with specific treatment options. This study aims to identify the prevalence in primary care and to compare patient characteristics to those with normal-renin hypertension and primary aldosteronism (PA).
Methods
In a cohort study, patients with treatment-naïve hypertension were screened for PA with plasma aldosterone and direct renin concentrations. Patients with an elevated aldosterone-to-renin ratio (≥70pmol/mU (≥2.5ng/dL:mU/L)) underwent confirmatory testing. All screened patients were then classified as having 1) normal-renin hypertension, 2) low-renin hypertension (direct renin concentration <10mU/L (plasma renin activity ∼<1ng/ml/hr) and not meeting the criteria for PA), or, 3) confirmed PA.
Results
Of the 261 patients, 69 (26.4%) had low-renin hypertension, 136 (51.9%) had normal renin hypertension and 47 (18.0%) had PA. Patients with low-renin hypertension were older and more likely to be female compared to normal-renin hypertension (57.1±12.8 years versus 51.8±14.0 years, p<0.05 and 68.1% versus 49.3%, p<0.05, respectively), but similar to PA (53.5±11.5 years and 55.3%). However, in an adjusted binomial logistic regression, there was no association between increasing age or gender and low-renin hypertension. The median aldosterone concentration was lower compared to patients with normal-renin hypertension and PA; 279pmol/L (216-355) versus 320pmol/L (231-472), p<0.05 and 419pmol/L (360-530), p<0.001.
Conclusion
At least a quarter of treatment-naïve hypertensive patients in primary care had a low direct renin concentration but did not meet the criteria for PA. Patient characteristics were similar, aside from a lower aldosterone concentration compared to patients with normal-renin hypertension and PA. Further research is needed to understand the underlying pathophysiology of low-renin hypertension and the optimal first-line treatment.